Deciphering the complex role of thrombospondin-1 in glioblastoma development.

  • NORLUX Neuro-Oncology Laboratory
March 08, 2019 By:
  • Daubon T
  • Leon C
  • Clarke K
  • Andrique L
  • Salabert L
  • Darbo E
  • Pineau R
  • Guerit S
  • Maitre M
  • Dedieu S
  • Jeanne A
  • Bailly S
  • Feige JJ
  • Miletic H
  • Rossi M
  • Bello L
  • Falciani F
  • Bjerkvig R
  • Bikfalvi A.

We undertook a systematic study focused on the matricellular protein Thrombospondin-1 (THBS1) to uncover molecular mechanisms underlying the role of THBS1 in glioblastoma (GBM) development. THBS1 was found to be increased with glioma grades. Mechanistically, we show that the TGFbeta canonical pathway transcriptionally regulates THBS1, through SMAD3 binding to the THBS1 gene promoter. THBS1 silencing inhibits tumour cell invasion and growth, alone and in combination with anti-angiogenic therapy. Specific inhibition of the THBS1/CD47 interaction using an antagonist peptide decreases cell invasion. This is confirmed by CD47 knock-down experiments. RNA sequencing of patient-derived xenograft tissue from laser capture micro-dissected peripheral and central tumour areas demonstrates that THBS1 is one of the gene with the highest connectivity at the tumour borders. All in all, these data show that TGFbeta1 induces THBS1 expression via Smad3 which contributes to the invasive behaviour during GBM expansion. Furthermore, tumour cell-bound CD47 is implicated in this process.

2019 Mar. Nat Commun.10(1):1146.
Other information